LifeArc appoints Head of Seed Funds
David Holbrook has been appointed to manage our newly created Seed Fund. The £25m fund will invest in innovative early stage therapeutics and biological research aiming to deliver new treatments for patients.
9 August 2018
Innovative diagnostic test for tuberculosis could save millions of lives
25 April 2018
We’re sponsoring ASTP Proton Annual Conference 2018, 23 – 25 May, Liege, Belgium.
23 January 2018
New partnership in artificial intelligence and machine learning for target discovery announced